Pub. L. 116-22, tit. V, sec. 504

THE BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY AND THE BIOSHIELD SPECIAL RESERVE FUND.

EnactedYear: 2019Length: 95 wordsOfficial source
SEC. 504. THE BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY AND THE BIOSHIELD SPECIAL RESERVE FUND.(a) BioShield Special Reserve Fund.—Section 319F–2(g)(1) (42 U.S.C. 247d–6b(g)(1)) is amended—(1) by striking “$2,800,000,000 for the period of fiscal years 2014 through 2018” and inserting “$7,100,000,000 for the period of fiscal years 2019 through 2028, to remain available until expended”; and(2) by striking the second sentence.(b) The Biomedical Advanced Research and Development Authority.—Section 319L(d)(2) (42 U.S.C. 247d–7e(d)(2)) is amended by striking “$415,000,000 for each of fiscal years 2014 through 2018” and inserting “$611,700,000 for each of fiscal years 2019 through 2023”.
Pub. L. 116-22, tit. V, sec. 504: THE BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY AND THE BIOSHIELD SPECIAL RESERVE FUND. | Justis AI